April 5, 2022
The University of Cincinnati's Shimul Shah, MD, was featured in a MedPage Today article highlighting recent research on the success of living donor transplants for patients with unresectable colorectal cancer liver metastases.
April 18, 2022
Yahoo! News featured University of Cincinnati research into the use of Optune devices that provide electrical field treatment to the brain as a treatment for glioblastomas.
November 9, 2022
WCPO featured the University of Cincinnati's Rifat Wahab in an article about racial disparities in breast cancer diagnoses and work being done to address the issue.
October 25, 2022
National media outlets highlighted the results of the first-in-human trial of FLASH radiotherapy, led by University of Cincinnati Cancer Center researchers.
May 27, 2022
The University of Cincinnati's John Breneman, MD, spoke with Imaging Technology News about the completion of enrollment of the FAST-01 trial, the first FLASH proton therapy trial completed in humans.
June 28, 2022
MSN highlighted the University of Cincinnati's Jordan Kharofa and his recent research on how diet and the microbiome affect colorectal cancer risks in young populations.
June 6, 2022
The University of Cincinnati's Atsuo Sasaki and an international team of collaborators have been awarded a Human Frontier Science Program research grant to learn more about how cells migrate, with an ultimate goal of developing new treatments to prevent cancer growth and spread.
August 10, 2022
Medium featured the research of the University of Cincinnati's Jiajie Diao, PhD, who recently published a paper showing early results that light-activated proteins can help normalize dysfunction within cells.
November 21, 2022
The University of Cincinnati Cancer Center's Davendra Sohal joined 55KRC's Simply Medicine program to discuss pancreatic cancer clinical trial options and screening during Pancreatic Cancer Awareness Month.
April 3, 2023
University of Cincinnati researchers recently published findings in the journal Cancer that found several enriched species, associated with enhanced tumor immune response, in the microbiomes of long-term pancreatic cancer survivors.